Chronic Diffuse Lung Diseases

Practical Pulmonary Pathology: A Diagnostic Approach A Volume in the Pattern Recognition Series

Volumn , Issue , 2017, Pages 227-298

  Hashisako, Mikiko ^a   Fukuoka, Junya ^a,b,c,d   Smith, Maxwell L ^e  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^c NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e MAYO CLINIC   (United States)

Author keywords

Chronic berylliosis; Chronic eosinophilic pneumonia; Cryptogenic organizing pneumonia; Desquamative interstitial pneumonia; Hypersensitivity pneumonitis; Idiopathic pleuroparenchymal fibroelastosis; Interstitial pneumonia with autoimmune features; Lymphoid interstitial pneumonia; Nonspecific interstitial pneumonia; Polymyositis dermatomyositis; Progressive systemic sclerosis; Pulmonary Langerhans cell histiocytosis; Respiratory bronchiolitis associated interstitial lung disease; Rheumatoid arthritis; Sarcoidosis; Sj gren syndrome; Systemic lupus erythematosus; Usual interstitial pneumonia

Indexed keywords

EID: 85054276138     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-323-44284-8.00008-9     Document Type: Chapter

References (498)

1. Leslie K, Colby T Classification and pathology of diffuse interstitial lung disease. Semin Clin Immunol 1999, 1:7-15.
2. Leslie KO My approach to interstitial lung disease using clinical, radiological and histopathological patterns. J Clin Pathol 2009, 62(5):387-401.
3. Leslie KO, Gruden JF, Parish JM, Scholand MB Transbronchial biopsy interpretation in the patient with diffuse parenchymal lung disease. Arch Pathol Lab Med 2007, 131(3):407-423.
4. Elicker B, Pereira CA, Webb R, Leslie KO High-resolution computed tomography patterns of diffuse interstitial lung disease with clinical and pathological correlation. J Bras Pneumol 2008, 34(9):715-744.
5. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000, 161(2 Pt 1):646-664.
6. American Thoracic Society/European Respiratory Society International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am Rev Respir Crit Care Med 2002, 165(2):227-304.
7. Liebow AL, Carrington CB The interstitial pneumonias. Frontiers of Pulmonary Radiology: Pathophysiologic, Roentgenographic and Radioisotopic Considerations 1969, 102-141. Grune & Stratton, New York. M. Simon, E.J. Potchen, M. LeMay (Eds.).
8. Katzenstein AL Idiopathic interstitial pneumonia: classification and diagnosis. Monogr Pathol 1993, 36:1-31.
9. Katzenstein AL, Myers JL Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol 2000, 24(1):1-3.
10. Crystal R, Fulmer JD, Roberts WC, et al. Idiopathic pulmonary fibrosis: clinical histologic, radiographic, physiologic, scintigraphic, cytologic and biochemical aspects. Ann Intern Med 1976, 85:769-788.
11. Carrington CB, Gaensler EA, Coutu RE, et al. Usual and desquamative interstitial pneumonia. Chest 1976, 69(suppl 2):261-263.
12. Aubry MC, Wright JL, Myers JL The pathology of smoking-related lung diseases. Clin Chest Med 2000, 21(1):11-35. vii.
13. Ohori N, Sciurba FC, Owens GR, Hodgson MJ, Yousem SA Giant-cell interstitial pneumonia and hard-metal pneumoconiosis. A clinicopathologic study of four cases and review of the literature. Am J Surg Pathol 1989, 13(7):581-587.
14. Lewis CC, Yang JY, Huang X, et al. Disease-specific gene expression profiling in multiple models of lung disease. Am J Respir Crit Care Med 2008, 177(4):376-387.
15. Katzenstein A, Myers J, Mazur M Acute interstitial pneumonia: a clinicopathologic, ultrastructural, and cell kinetic study. Am J Surg Pathol 1986, 10:256-267.
16. Katzenstein AL, Fiorelli RF Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994, 18(2):136-147.
17. Epler GR, Colby TV, McLoud TC, Carrington CB, Gaensler EA Bronchiolitis obliterans organizing pneumonia. N Engl J Med 1985, 312(3):152-158.
18. Travis WD, Costabel U, Hansell DM, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013, 188(6):733-748.
19. Travis WD, Hunninghake G, King TE, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med 2008, 177(12):1338-1347.
20. Leslie KO Pathology of the idiopathic interstitial pneumonias. Exp Lung Res 2005, 31(suppl 1):23-40.
21. Gough J Differential diagnosis in the pathology of asbestosis. Ann N Y Acad Sci 1965, 132:368-372.
22. Gadek J, Hunninghake G, Schoenberger C, Fells G, Crystal R Pulmonary asbestosis and idiopathic pulmonary fibrosis: pathogenetic parallels. Chest 1981, 80(suppl 1):63-64.
23. Yamamoto S Histopathological features of pulmonary asbestosis with particular emphasis on the comparison with those of usual interstitial pneumonia. Osaka City Med J 1997, 43(2):225-242.
24. Leslie K, King TE, Low R Smooth muscle actin is expressed by air space fibroblast-like cells in idiopathic pulmonary fibrosis and hypersensitivity pneumonitis. Chest 1991, 99(suppl 3):47S-48S.
25. Adler BD, Padley SP, Müller NL, Remy-Jardin M, Remy J Chronic hypersensitivity pneumonitis: high resolution CT and radiographic features in 16 patients. Radiology 1992, 185:91-95.
26. Lynch DA, Newell JD, Logan PM, King TE, Müller NL Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis. AJR Am J Roentgenol 1995, 165(4):807-811.
27. Hunninghake G, Fauci A Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979, 119:471-503.
28. Colby TV Pathology of the lung in collagen vascular diseases. The Lung Rheumatic Diseases 1990, 145-178. Marcel Dekker, New York. G. Cannon, G. Zimmerman (Eds.).
29. Leslie KO, Trahan S, Gruden J Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med 2007, 28(4):369-378.
30. Lamblin C, Bergoin C, Saelens T, Wallaert B Interstitial lung diseases in collagen vascular diseases. Eur Respir J Suppl 2001, 32:69s-80s.
31. Rossi SE, Erasmus JJ, McAdams HP, Sporn TA, Goodman PC Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000, 20(5):1245-1259.
32. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183(6):788-824.
33. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174(7):810-816.
34. Coultas DB Epidemiology of idiopathic pulmonary fibrosis. Semin Respir Med 1993, 14:181-196.
35. Guerry-Force M, Müller NL, Wright JL, et al. A comparison of bronchiolitis obliterans with organizing pneumonia, usual interstitial pneumonia and small airways disease. Am Rev Respir Dis 1987, 135:705-712.
36. Staples C, Müller NL, Vedal S, et al. Usual interstitial pneumonia: correlations of CT with clinical, functional and radiologic findings. Radiology 1987, 162:377-381.
37. Epler G, McLoud TC, Gaensler EA, Mikus JP, Carrington CB Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med 1978, 298:934-939.
38. Akira M, Sakatani M, Ueda E Idiopathic pulmonary fibrosis: progression of honeycombing at thin-section CT. Radiology 1993, 189(3):687-691.
39. Nishimura K, Itoh H High-resolution computed tomographic features of bronchiolitis obliterans organizing pneumonia. Chest 1992, 102:26S-31S.
40. Lynch DA Ground glass attenuation on CT in patients with idiopathic pulmonary fibrosis. Chest 1996, 110(2):312-313.
41. Kazerooni EA, Martinez FJ, Flint A, et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997, 169(4):977-983.
42. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001, 164(2):193-196.
43. Kropski JA, Pritchett JM, Mason WR, et al. Bronchoscopic cryobiopsy for the diagnosis of diffuse parenchymal lung disease. PLoS ONE 2013, 8(11):e78674.
44. Casoni GL, Tomassetti S, Cavazza A, et al. Transbronchial lung cryobiopsy in the diagnosis of fibrotic interstitial lung diseases. PLoS ONE 2014, 9(2):e86716.
45. Pajares V, Puzo C, Castillo D, et al. Diagnostic yield of transbronchial cryobiopsy in interstitial lung disease: a randomized trial. Respirology 2014, 19(6):900-906.
46. Katzenstein A, Myers JL, Prophet WD, Corley LS, Shin MS Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study. Am J Surg Pathol 1986, 10:373-376.
47. Lee JS, Gong G, Song KS, Kim DS, Lim TH Usual interstitial pneumonia: relationship between disease activity and the progression of honeycombing at thin-section computed tomography. J Thorac Imaging 1998, 13(3):199-203.
48. Myers JL NSIP, UIP, and the ABCs of idiopathic interstitial pneumonias. Eur Respir J 1998, 12(5):1003-1004.
49. Nagao T, Nagai S, Kitaichi M, et al. Usual interstitial pneumonia: idiopathic pulmonary fibrosis versus collagen vascular diseases. Respiration 2001, 68(2):151-159.
50. Cool CD, Groshong SD, Rai PR, et al. Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum. Am J Respir Crit Care Med 2006, 174(6):654-658.
51. Flaherty KR, Colby TV, Travis WD, et al. Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med 2003, 167(10):1410-1415.
52. Kondoh Y, Taniguchi H, Kawabata Y, et al. Acute exacerbation in idiopathic pulmonary fibrosis. Analysis of clinical and pathologic findings in three cases. Chest 1993, 103(6):1808-1812.
53. Collard HR, Moore BB, Flaherty KR, et al. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2007, 176(7):636-643.
54. Panos RJ, Mortenson RL, Niccoli SA, King TE Clinical deterioration in patients with idiopathic pulmonary fibrosis: causes and assessment. Am J Med 1990, 88(4):396-404.
55. Kim DS, Park JH, Park BK, et al. Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features. Eur Respir J 2006, 27(1):143-150.
56. Katzenstein AL, Zisman DA, Litzky LA, Nguyen BT, Kotloff RM Usual interstitial pneumonia: histologic study of biopsy and explant specimens. Am J Surg Pathol 2002, 26(12):1567-1577.
57. Flaherty KR, Travis WD, Colby TV, et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001, 164(9):1722-1727.
58. Noth I, Martinez FJ Recent advances in idiopathic pulmonary fibrosis. Chest 2007, 132(2):637-650.
59. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998, 157(1):199-203.
60. Raghu G, Anstrom KJ, King TE, Lasky JA, Martinez FJ Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med 2012, 366(21):1968-1977. Idiopathic Pulmonary Fibrosis Clinical Research Network.
61. King TE, Bradford WZ, Castro-Bernardini S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014, 370(22):2083-2092.
62. Raghu G, Brown KK, Costabel U, et al. Treatment of idiopathic pulmonary fibrosis with etanercept: an exploratory, placebo-controlled trial. Am J Respir Crit Care Med 2008, 178(9):948-955.
63. Ask K, Martin GE, Kolb M, Gauldie J Targeting genes for treatment in idiopathic pulmonary fibrosis: challenges and opportunities, promises and pitfalls. Proc Am Thorac Soc 2006, 3(4):389-393.
64. Grutters JC, du Bois RM Genetics of fibrosing lung diseases. Eur Respir J 2005, 25(5):915-927.
65. Wang Y, Kuan PJ, Xing C, et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 2009, 84(1):52-59.
66. Steele MP, Speer MC, Loyd JE, et al. Clinical and pathologic features of familial interstitial pneumonia. Am J Respir Crit Care Med 2005, 172(9):1146-1152.
67. Armanios MY, Chen JJ, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 2007, 356(13):1317-1326.
68. Kitaichi M Pathologic features and the classification of interstitial pneumonia of unknown etiology. Bull Chest Dis Res Inst Kyoto Univ 1990, 23(1-2):1-18.
69. Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998, 12(5):1010-1019.
70. Cottin V, Donsbeck AV, Revel D, Loire R, Cordier JF Nonspecific interstitial pneumonia. Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998, 158(4):1286-1293.
71. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999, 160(3):899-905.
72. Park JS, Lee KS, Kim JS, et al. Nonspecific interstitial pneumonia with fibrosis: radiographic and CT findings in seven patients. Radiology 1995, 195(3):645-648.
73. Hartman TE, Swensen SJ, Hansell DM, et al. Nonspecific interstitial pneumonia: variable appearance at high-resolution chest CT. Radiology 2000, 217(3):701-705.
74. Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease. Am J Respir Crit Care Med 2007, 176(7):691-697.
75. Xu W, Xiao Y, Liu H, et al. Nonspecific interstitial pneumonia: clinical associations and outcomes. BMC Pulm Med 2014, 14:175.
76. Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015, 46(4):976-987.
77. Travis WD, Matsui K, Moss J, Ferrans VJ Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000, 24(1):19-33.
78. Davison AG, Heard BE, McAllister WA, Turner-Warwick ME Cryptogenic organizing pneumonitis. Q J Med 1983, 52:382-394.
79. Yousem SA, Lohr RH, Colby TV Idiopathic bronchiolitis obliterans organizing pneumonia/cryptogenic organizing pneumonia with unfavorable outcome: pathologic predictors. Mod Pathol 1997, 10(9):864-871.
80. Izumi T, Nagai S, Nishimura K, et al. BALF cell findings in patients with BOOP, particularly in comparison with UIP. Nihon Kyobu Shikkan Gakkai Zasshi 1989, 27(4):474-480.
81. King TJ, Mortensen R Cryptogenic organizing pneumonitis. Chest 1992, 102:8S-13S.
82. Müller NL, Guerry-Force ML, Staples CA, et al. Differential diagnosis of bronchiolitis obliterans with organizing pneumonia and usual interstitial pneumonia: clinical, functional, and radiologic findings. Radiology 1987, 162(1 pt1):151-156.
83. Cordier JF, Loire R, Brune J Idiopathic bronchiolitis obliterans organizing pneumonia: definition of clinical profiles in a series of 16 patients. Chest 1989, 96:999-1004.
84. Müller NL, Staples CA, Miller RR Bronchiolitis obliterans organizing pneumonia: CT features in 14 patients. AJR Am J Roentgenol 1990, 154(5):983-987.
85. Lee KS, Kullnig P, Hartman TE, Müller NL Cryptogenic organizing pneumonia. CT findings in 43 patients. AJR Am J Roentgenol 1994, 62:543-546.
86. Preidler KW, Szolar DM, Moelleken S, Tripp R, Schreyer H Distribution pattern of computed tomography findings in patients with bronchiolitis obliterans organizing pneumonia. Invest Radiol 1996, 31(5):251-255.
87. Akira M, Yamamoto S, Sakatani S Bronchiolitis obliterans organizing pneumonia manifesting as multiple large nodules or masses. AJR Am J Roentgenol 1998, 170(2):291-295.
88. Izumi T, Kitaichi M, Nishimura K, Nagai S Bronchiolitis obliterans organizing pneumonia. Clinical features and differential diagnosis. Chest 1992, 102(3):715-719.
89. King TE BOOP: an important cause of migratory pulmonary infiltrates. Eur Respir J 1995, 8(2):193-195.
90. Bouchardy LM, Kuhlman JE, Ball WC, et al. CT findings in bronchiolitis obliterans organizing pneumonia (BOOP) with radiographic, clinical, and histologic correlation. J Comput Assist Tomogr 1993, 17:352-357.
91. Colby TV Pathologic aspects of bronchiolitis obliterans organizing pneumonia. Chest 1992, 102(suppl 1):38S-43S.
92. Kitaichi M Bronchiolitis obliterans organizing pneumonia (BOOP). Basic and Clinical Aspects of Pulmonary Fibrosis 1994, 463-488. CRC Press, Boca Raton. T. Takishima (Ed.).
93. Nishino M, Mathai SK, Schoenfeld D, Digumarthy SR, Kradin RL Clinicopathologic features associated with relapse in cryptogenic organizing pneumonia. Hum Pathol 2014, 45(2):342-351.
94. Cordier JF Cryptogenic organizing pneumonitis. Bronchiolitis obliterans organizing pneumonia. Clin Chest Med 1993, 14(4):677-692.
95. Lee JW, Lee KS, Lee HY, et al. Cryptogenic organizing pneumonia: serial high-resolution CT findings in 22 patients. AJR Am J Roentgenol 2010, 195(4):916-922.
96. Beardsley B, Rassl D Fibrosing organising pneumonia. J Clin Pathol 2013, 66(10):875-881.
97. Niewoehner D, Kleinerman J, Rice D Pathologic changes in the the peripheral airways in young cigarette smokers. N Engl J Med 1974, 291:755-758.
98. Myers JL, Veal CF, Shin MS, Katzenstein AL Respiratory bronchiolitis causing interstitial lung disease. A clinicopathologic study of six cases. Am Rev Respir Dis 1987, 135(4):880-884.
99. Heyneman LE, Ward S, Lynch DA, et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process. AJR Am J Roentgenol 1999, 173(6):1617-1622.
100. Katzenstein AL, Mukhopadhyay S, Zanardi C, Dexter E Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens. Hum Pathol 2010, 41(3):316-325.
101. Kawabata Y, Hoshi E, Murai K, et al. Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course. Histopathology 2008, 53(6):707-714.
102. Yousem SA, Colby TV, Gaensler EA Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989, 64(11):1373-1380.
103. King TE Respiratory bronchiolitis-associated interstitial lung disease. Clin Chest Med 1993, 14(4):693-698.
104. Moon J, du Bois RM, Colby TV, Hansell D, Nicholson A Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. Thorax 1999, 54(11):1009-1014.
105. Katzenstein AL Smoking-related interstitial fibrosis (SRIF), pathogenesis and treatment of usual interstitial pneumonia (UIP), and transbronchial biopsy in UIP. Mod Pathol 2012, 25(suppl 1):S68-S78.
106. Yousem SA Respiratory bronchiolitis-associated interstitial lung disease with fibrosis is a lesion distinct from fibrotic nonspecific interstitial pneumonia: a proposal. Mod Pathol 2006, 19(11):1474-1479.
107. Portnoy J, Veraldi KL, Schwarz MI, et al. Respiratory bronchiolitis-interstitial lung disease: long-term outcome. Chest 2007, 131(3):664-671.
108. Carrington CB, Gaensler EA, Coutu RE, FitzGerald MX, Gupta RG Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978, 298(15):801-809.
109. Katzenstein AL, Myers JL Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998, 157(4 pt1):1301-1315.
110. Hartman TE, Primack SL, Swensen SJ, et al. Desquamative interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1993, 187(3):787-790.
111. Gruden JF, Webb WR CT findings in a proved case of respiratory bronchiolitis. AJR Am J Roentgenol 1993, 161(1):44-46.
112. Nicholson AG, Wotherspoon AC, Diss TC, et al. Pulmonary B-cell non-Hodgkin's lymphomas. The value of immunohistochemistry and gene analysis in diagnosis. Histopathology 1995, 26(5):395-403.
113. Nicholson AG, Wotherspoon AC, Diss TC, et al. Reactive pulmonary lymphoid disorders. Histopathology 1995, 26(5):405-412.
114. Nicholson AG, Wotherspoon AC, Jones AL, et al. Cell non-Hodgkin's lymphoma associated with autoimmune disorders: a clinicopathological review of six cases. Eur Respir J 1996, 9(10):2022-2025.
115. Koss MN Pulmonary lymphoproliferative disorders. Monogr Pathol 1993, 18(36):145-194.
116. Herbert A, Walters MT, Cawley MI, Godfrey RC Lymphocytic interstitial pneumonia identified as lymphoma of mucosa-associated lymphoid tissue. J Pathol 1985, 146(2):129-138.
117. Schuurman HJ, Gooszen HC, Tan IW, et al. Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjögren's syndrome. Histopathology 1987, 11(11):1193-1204.
118. Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006, 28(2):364-369.
119. Strimlan C, Rosenow EC, Weiland LH, Brown LR Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978, 88:616-621.
120. Liebow AA, Carrington CB Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973, 57:809-843.
121. Strimlan CV, Rosenow EC, Divertie MB, Harrison EG Pulmonary manifestations of Sjögren's syndrome. Chest 1976, 70(03):354-361.
122. DeCoteau WE, Tourville D, Ambrus JL, et al. Lymphoid interstitial pneumonia and autoerythrocyte sensitization syndrome. A case with deposition of immunoglobulins on the alveolar basement membrane. Arch Intern Med 1974, 134(3):519-522.
123. Julsrud PR, Brown LR, Li CY, Rosenow EC, Crowe JK Pulmonary processes of mature-appearing lymphocytes: pseudolymphoma, well-differentiated lymphocytic lymphoma, and lymphocytic interstitial pneumonitis. Radiology 1978, 127(2):289-296.
124. Schwarz MI A man with dyspnea, productive cough, and chest radiograph showing hyperinflation and a diffuse nodular pattern. Chest 1998, 113(4):1123-1124.
125. Johkoh T, Ichikado K, Akira M, et al. Lymphocytic interstitial pneumonia: follow-up CT findings in 14 patients. J Thorac Imaging 2000, 15(3):162-167.
126. Macfarlane A, Davies D Diffuse lymphoid interstitial pneumonia. Thorax 1973, 28(6):768-776.
127. Johkoh T, Müller NL, Pickford HA, et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999, 212(2):567-572.
128. Silva CI, Flint JD, Levy RD, Müller NL Diffuse lung cysts in lymphoid interstitial pneumonia: high-resolution CT and pathologic findings. J Thorac Imaging 2006, 21(3):241-244.
129. Lohrmann C, Uhl M, Warnatz K, et al. High-resolution CT imaging of the lung for patients with primary Sjögren's syndrome. Eur J Radiol 2004, 52(2):137-143.
130. Torii K, Ogawa K, Kawabata Y, et al. Lymphoid interstitial pneumonia as a pulmonary lesion of idiopathic plasmacytic lymphadenopathy with hyperimmunoglobulinemia. Intern Med 1994, 33(4):237-241.
131. Strimlan CV Pulmonary function in patients with primary Sjögren's syndrome. Ann Rheum Dis 2001, 60(4):429.
132. Palmas A, Tefferi A, Myers JL, et al. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol 1998, 100(4):680-687.
133. Grieco M, Chinoy-Acharya P Lymphoid interstitial pneumonia associated with the acquired immune deficiency syndrome. Am Rev Respir Dis 1985, 131:952-955.
134. Berdon WE, Mellins RB, Abramson SJ, Ruzal-Shapiro C Pediatric HIV infection in its second decade-the changing pattern of lung involvement. Clinical, plain film, and computed tomographic findings. Radiol Clin North Am 1993, 31(3):453-463.
135. Ikeogu MO, Wolf B, Mathe S Pulmonary manifestations in HIV seropositivity and malnutrition in Zimbabwe. Arch Dis Child 1997, 76(2):124-128.
136. Khare MD, Sharland M Pulmonary manifestations of pediatric HIV infection. Indian J Pediatr 1999, 66(6):895-904.
137. Church JA Lymphoid interstitial pneumonia and rheumatoid arthritis. J Pediatr 1985, 107(3):485.
138. Amitani RNA, Kuze F Idiopathic pulmonary upper lobe fibrosis (IPUF). Kokyu 1992, 11:693-699. in Japanese.
139. Frankel SK, Cool CD, Lynch DA, Brown KK Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity. Chest 2004, 126(6):2007-2013.
140. Reddy TL, Tominaga M, Hansell DM, et al. Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J 2012, 40(2):377-385.
141. Watanabe K, Nagata N, Kitasato Y, et al. Rapid decrease in forced vital capacity in patients with idiopathic pulmonary upper lobe fibrosis. Respir Investig 2012, 50(3):88-97.
142. Black L, Katz S Respiratory Disease: Task Force Report on Problems, Research Approaches, Needs 1977, Department of Health, Education, and Welfare, National Heart and Lung Institute, Washington, DC.
143. Banks J, Banks C, Cheong B, et al. An epidemiological and clinical investigation of pulmonary function and respiratory symptoms in patients with rheumatoid arthritis. Q J Med 1992, 85:795-806.
144. Cheema GS, Quismorio FP Interstitial lung disease in systemic sclerosis. Curr Opin Pulm Med 2001, 7(5):283-290.
145. Minai OA, Dweik RA, Arroliga AC Manifestations of scleroderma pulmonary disease. Clin Chest Med 1998, 19(4):713-731. viii-ix.
146. Cheema GS, Quismorio FP Interstitial lung disease in systemic lupus erythematosus. Curr Opin Pulm Med 2000, 6(5):424-429.
147. Murin S, Wiedemann HP, Matthay RA Pulmonary manifestations of systemic lupus erythematosus. Clin Chest Med 1998, 19(4):641-665. viii.
148. Dickey BF, Myers AR Pulmonary disease in polymyositis/dermatomyositis. Semin Arthritis Rheum 1984, 14(1):60-76.
149. Ito I, Nagai S, Kitaichi M, et al. Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 2005, 171(6):632-638.
150. Koyama M, Johkoh T, Honda O, et al. Pulmonary involvement in primary Sjögren's syndrome: spectrum of pulmonary abnormalities and computed tomography findings in 60 patients. J Thorac Imaging 2001, 16(4):290-296.
151. Sarkar PK, Patel N, Furie RA, Talwar A Pulmonary manifestations of primary Sjögren's syndrome. Indian J Chest Dis Allied Sci 2009, 51(2):93-101.
152. Prakash UB Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998, 19(4):733-746. ix.
153. Tillie-Leblond I, Wislez M, Valeyre D, et al. Interstitial lung disease and anti-Jo-1 antibodies: difference between acute and gradual onset. Thorax 2008, 63(1):53-59.
154. Ellman P, Ball RE "Rheumatoid disease" with joint and pulmonary manifestations. BMJ 1948, 2:816-820.
155. Gabbay E, Tarala R, Will R, et al. Interstitial lung disease in recent onset rheumatoid arthritis. Am J Respir Crit Care Med 1997, 156(2 pt1):528-535.
156. Anaya JM, Diethelm L, Ortiz LA, et al. Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995, 24(4):242-254.
157. Hakala M Poor prognosis in patients with rheumatoid arthritis hospitalized for interstitial lung fibrosis. Chest 1988, 93(1):114-118.
158. Athreya BH, Doughty RA, Bookspan M, et al. Pulmonary manifestations of juvenile rheumatoid arthritis. A report of eight cases and review. Clin Chest Med 1980, 1(3):361-374.
159. Saag KG, Kolluri S, Koehnke RK, et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. Arthritis Rheum 1996, 39(10):1711-1719.
160. Akira M, Sakatani M, Hara H Thin-section CT findings in rheumatoid arthritis-associated lung disease: CT patterns and their courses. J Comput Assist Tomogr 1999, 23(6):941-948.
161. Remy-Jardin M, Remy J, Cortet B, Mauri F, Delcambre B Lung changes in rheumatoid arthritis: CT findings. Radiology 1994, 193(2):375-382.
162. Hunninghake GW, Fauci AS Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis 1979, 119(3):471-503.
163. Hubbard R, Venn A The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis. Rheumatology (Oxford) 2002, 41(6):676-679.
164. Laitinen O, Nissilä M, Salorinne Y, Aalto P Pulmonary involvement in patients with rheumatoid arthritis. Scand J Respir Dis 1975, 56:297-304.
165. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005, 127(6):2019-2027.
166. Schwarz MI, Matthay RA, Sahn SA, et al. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) 1976, 55(1):89-104.
167. Khanna D, Brown KK, Clements PJ, et al. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol 2010, 28(2 suppl 58):S55-S62.
168. Hunninghake GW, Gadek JE, Kawanami O, Ferrans VJ, Crystal RG Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol 1979, 97:149-206.
169. Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002, 165(12):1581-1586.
170. Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19(2):121-127.
171. Kim EA, Johkoh T, Lee KS, et al. Interstitial pneumonia in progressive systemic sclerosis: serial high-resolution CT findings with functional correlation. J Comput Assist Tomogr 2001, 25(5):757-763.
172. Cozzi F, Chiesura Corona M, Rizzi M, et al. Lung fibrosis quantified by HRCT in scleroderma patients with different disease forms and ANA specificities. Reumatismo 2001, 53(1):55-62.
173. Yamane K, Ihn H, Asano Y, et al. Clinical and laboratory features of scleroderma patients with pulmonary hypertension. Rheumatology (Oxford) 2000, 39(11):1269-1271.
174. Johnson DA, Drane WE, Curran J, et al. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration. Arch Intern Med 1989, 149(3):589-593.
175. Montesi A, Pesaresi A, Cavalli ML, et al. Oropharyngeal and esophageal function in scleroderma. Dysphagia 1991, 6(4):219-223.
176. Tashkin DP, Elashoff R, Clements PJ, et al. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med 2007, 176(10):1026-1034.
177. McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood 2002, 100(5):1602-1610.
178. Dubois E, Tufanelli DL Clinical manifestations of systemic lupus erythematosus. JAMA 1964, 190:104-111.
179. Eisenberg H, Dubois EL, Sherwin RP, Balchum OJ Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973, 79:37-45.
180. Gammon RB, Bridges TA, al-Nezir H, Alexander CB, Kennedy JI Bronchiolitis obliterans organizing pneumonia associated with systemic lupus erythematosus. Chest 1992, 102:1171-1174.
181. Myers JL, Katzenstein AA Microangiitis in lupus-induced pulmonary hemorrhage. Am J Clin Pathol 1986, 85(5):552-556.
182. Chang MY, Fang JT, Chen YC, Huang CC Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Ren Fail 2002, 24(6):791-802.
183. Santos-Ocampo AS, Mandell BF, Fessler BJ Alveolar hemorrhage in systemic lupus erythematosus: presentation and management. Chest 2000, 118(4):1083-1090.
184. Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases with acute lupus pneumonitis. Medicine (Baltimore) 1974, 54:397-409.
185. Kim JS, Lee KS, Koh EM, et al. Thoracic involvement of systemic lupus erythematosus: clinical, pathologic, and radiologic findings. J Comput Assist Tomogr 2000, 24(1):9-18.
186. Hughson MD, He Z, Henegar J, McMurray R Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 2001, 125(4):475-483.
187. Bankier AA, Kiener HP, Wiesmayr MN, et al. Discrete lung involvement in systemic lupus erythematosus: CT assessment. Radiology 1995, 196(3):835-840.
188. Fenlon HM, Doran M, Sant SM, Breatnach E High-resolution chest CT in systemic lupus erythematosus. AJR Am J Roentgenol 1996, 166(2):301-307.
189. Sant SM, Doran M, Fenelon HM, Breatnach ES Pleuropulmonary abnormalities in patients with systemic lupus erythematosus: assessment with high resolution computed tomography, chest radiography and pulmonary function tests. Clin Exp Rheumatol 1997, 15(5):507-513.
190. Ooi GC, Ngan H, Peh WC, Mok MY, Ip M Systemic lupus erythematosus patients with respiratory symptoms: the value of HRCT. Clin Radiol 1997, 52(10):775-781.
191. Susanto I, Peters JI Acute lupus pneumonitis with normal chest radiograph. Chest 1997, 111(6):1781-1783.
192. Anderson NE, Ali MR The lupus anticoagulant, pulmonary thromboembolism, and fatal pulmonary hypertension. Ann Rheum Dis 1984, 43(5):760-763.
193. Howe HS, Boey ML, Fong KY, Feng PH Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis 1988, 47(10):869-872.
194. Auger WR, Permpikul P, Moser KM Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 1995, 99(4):392-396.
195. Urman JD, Rothfield NF Corticosteroid treatment in systemic lupus erythematosus. Survival studies. JAMA 1977, 238(21):2272-2276.
196. Rosner S, Ginzler EM, Diamond HS, et al. A multicenter study of outcome in systemic lupus erythematosus. II. Causes of death. Arthritis Rheum 1982, 25(6):612-617.
197. Bohan A, Peter JB, Bowman RL, Pearson CM Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977, 56(4):255-286.
198. Bohan A History and classification of polymyositis and dermatomyositis. Clin Dermatol 1988, 6(2):3-8.
199. Nobutoh T, Kohda M, Doi Y, Ueki H An autopsy case of dermatomyositis with rapidly progressive diffuse alveolar damage. J Dermatol 1998, 25(1):32-36.
200. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990, 141(3):727-733.
201. Targoff IN Laboratory testing in the diagnosis and management of idiopathic inflammatory myopathies. Rheum Dis Clin North Am 2002, 28(4):859-890. viii.
202. Mammen AL Dermatomyositis and polymyositis: clinical presentation, autoantibodies, and pathogenesis. Ann NY Acad Sci 2010, 1184:134-153.
203. Hamaguchi Y, Kuwana M, Hoshino K, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. Arch Dermatol 2011, 147(4):391-398.
204. Yoshida S, Akizuki M, Mimori T, et al. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases. A marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983, 26(5):604-611.
205. Mathews MB, Reichlin M, Hughes GR, Bernstein RM A synthetase, a second myositis-related autoantibody. J Exp Med 1984, 160(2):420-434.
206. Bunn CC, Bernstein RM, Mathews MB Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis. J Exp Med 1986, 163(5):1281-1291.
207. Dang CV, Dang CV Higher eukaryotic aminoacyl-tRNA synthetases in physiologic and pathologic states. Mol Cell Biochem 1986, 71(2):107-120.
208. Targoff IN Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. J Immunol 1990, 144(5):1737-1743.
209. Hirakata M, Mimori T, Akizuki M, et al. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. Arthritis Rheum 1992, 35(4):449-456.
210. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001, 164(7):1182-1185.
211. Hepper N, Ferguson RH, Howard FM Three types of pulmonary involvement in polymyositis. Med Clin North Am 1964, 48:1031-1042.
212. Benbassat J, Gefel D, Larholt K, et al. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985, 28(3):249-255.
213. Ikezoe J, Johkoh T, Kohno N, et al. High-resolution CT findings of lung disease in patients with polymyositis and dermatomyositis. J Thorac Imaging 1996, 11(4):250-259.
214. Whaley K, Alspaugh MA Sjögren's syndrome. Textbook of Rheumatology 1985, 956. WB Saunders, Philadelphia. 2nd ed. H. Kelley, E.D. Harris, S. Ruddy, C.B. Sledge (Eds.).
215. Baruch HH, Firooznia H, Sackler JP, et al. Pulmonary disorders associated with Sjögren's syndrome. Rev Interam Radiol 1977, 2(2):77-81.
216. Franquet T, Giménez A, Monill JM, Díaz C, Geli C Primary Sjögren's syndrome and associated lung disease: CT findings in 50 patients. AJR Am J Roentgenol 1997, 169(3):655-658.
217. Deheinzelin D, Capelozzi VL, Kairalla RA, et al. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996, 154(3 Pt 1):794-799.
218. Reveille JD, Wilson RW, Provost TT, Bias WB, Arnett FC Primary Sjögren's syndrome and other autoimmune diseases in families. Prevalence and immunogenetic studies in six kindreds. Ann Intern Med 1984, 101(6):748-756.
219. Meyer CA, Pina JS, Taillon D, Godwin JD Inspiratory and expiratory high-resolution CT findings in a patient with Sjögren's syndrome and cystic lung disease. AJR Am J Roentgenol 1997, 168(1):101-103.
220. Hansen LA, Prakash UB, Colby TV Pulmonary lymphoma in Sjögren's syndrome. Mayo Clin Proc 1989, 64(8):920-931.
221. Kokosi M, Riemer EC, Highland KB Pulmonary involvement in Sjögren syndrome. Clin Chest Med 2010, 31(3):489-500.
222. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Engl J Med 1969, 280:787-798.
223. Liebow A, Carrington C The eosinophilic pneumonias. Medicine (Baltimore) 1969, 48:251-285.
224. Gaensler E, Carrington C Peripheral opacities in chronic eosinophilic pneumonia: the photographic negative of pulmonary edema. AJR Am J Roentgenol 1977, 128:1-13.
225. Mayo J, Müller NL, Road J, Sisler J, Lillington G Chronic eosinophilic pneumonia: CT findings in six cases. AJR Am J Roentgenol 1989, 153:727-730.
226. Copper JA Drug-induced lung disease. Adv Intern Med 1997, 42:231-268.
227. Camus PH, Foucher P, Bonniaud PH, Ask K Drug-induced infiltrative lung disease. Eur Respir J Suppl 2001, 32:93s-100s.
228. Ozkan M, Dweik RA, Ahmad M Drug-induced lung disease. Cleve Clin J Med 2001, 68(9):782-785. 789-795.
229. Cuellar ML Drug-induced vasculitis. Curr Rheumatol Rep 2002, 4(1):55-59.
230. Ruangchira-Urai R, Colby TV, Klein J, et al. Nodular amiodarone lung disease. Am J Surg Pathol 2008, 32(11):1654-1660.
231. Camus P, Lombard JN, Perrichon M, et al. Bronchiolitis obliterans organising pneumonia in patients taking acebutolol or amiodarone. Thorax 1989, 44(9):711-715.
232. Kennedy JI, Myers JL, Plumb VJ, Fulmer JD Amiodarone pulmonary toxicity. Clinical, radiologic, and pathologic correlations. Arch Intern Med 1987, 147(1):50-55.
233. Musk AW, Pollard JA Pindolol and pulmonary fibrosis. BMJ 1979, 2(6190):581-582.
234. Sandler A, Gray R, Perry MC, et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006, 355(24):2542-2550.
235. Iacovino JR, Leitner J, Abbas AK, Lokich JJ, Snider GL Fatal pulmonary reaction from low doses of bleomycin. An idiosyncratic tissue response. JAMA 1976, 235(12):1253-1255.
236. Luna MA, Bedrossian CW, Lichtiger B, Salem PA Interstitial pneumonitis associated with bleomycin therapy. Am J Clin Pathol 1972, 58(5):501-510.
237. Feingold ML, Koss LG Effects of long-term administration of busulfan. Report of a patient with generalized nuclear abnormalities, carcinoma of vulva, and pulmonary fibrosis. Arch Intern Med 1969, 124(1):66-71.
238. Littler WA, Kay JM, Hasleton PS, Heath D Busulphan lung. Thorax 1969, 24(6):639-655.
239. Lombard CM, Churg A, Winokur S Pulmonary veno-occlusive disease following therapy for malignant neoplasms. Chest 1987, 92(5):871-876.
240. Mitsudo SM, Greenwald ES, Banerji B, Koss LG BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes. Cancer 1984, 54(4):751-755.
241. Forrester JM, Steele AW, Waldron JA, Parsons PE Crack lung: an acute pulmonary syndrome with a spectrum of clinical and histopathologic findings. Am Rev Respir Dis 1990, 142(2):462-467.
242. Murray RJ, Albin RJ, Mergner W, Criner GJ Diffuse alveolar hemorrhage temporally related to cocaine smoking. Chest 1988, 93(2):427-429.
243. Abdel Karim FW, Ayash RE, Allam C, Salem PA Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report. Oncology 1983, 40(3):174-176.
244. Patel AR, Shah PC, Rhee HL, Sassoon H, Rao KP Cyclophosphamide therapy and interstitial pulmonary fibrosis. Cancer 1976, 38(4):1542-1549.
245. Spector JI, Zimbler H, Ross JS Early-onset cyclophosphamide-induced interstitial pneumonitis. JAMA 1979, 242(26):2852-2854.
246. Slavin RE, Millan JC, Mullins GM Pathology of high dose intermittent cyclophosphamide therapy. Hum Pathol 1975, 6(6):693-709.
247. Read WL, Mortimer JE, Picus J Severe interstitial pneumonitis associated with docetaxel administration. Cancer 2002, 94(3):847-853.
248. Pfitzenmeyer P, Foucher P, Dennewald G, et al. Pleuropulmonary changes induced by ergoline drugs. Eur Respir J 1996, 9(5):1013-1019.
249. Liu V, White DA, Zakowski MF, et al. Pulmonary toxicity associated with erlotinib. Chest 2007, 132(3):1042-1044.
250. Gurjal A, An T, Valdivieso M, Kalemkerian GP Etoposide-induced pulmonary toxicity. Lung Cancer 1999, 26(2):109-112.
251. Inoue A, Saijo Y, Maemondo M, et al. Severe acute interstitial pneumonia and gefitinib. Lancet 2003, 361(9352):137-139.
252. Briasoulis E, Froudarakis M, Milionis HJ, et al. Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support. Respiration 2000, 67(6):680-683.
253. Tomioka R, King TE Gold-induced pulmonary disease: clinical features, outcome, and differentiation from rheumatoid lung disease. Am J Respir Crit Care Med 1997, 155(3):1011-1020.
254. Warnock ML, Ghahremani GG, Rattenborg C, Ginsberg M, Valenzuela J Pulmonary complication of heroin intoxication. Aspiration pneumonia and diffuse bronchiectasis. JAMA 1972, 219(8):1051-1053.
255. Karne S, D'Ambrosio C, Einarsson O, O'Connor PG Hypersensitivity pneumonitis induced by intranasal heroin use. Am J Med 1999, 107(4):392-395.
256. Petersen AG, Dodge M, Helwig FC Pulmonary changes associated with hexamethonium therapy. Arch Intern Med 1959, 103:285-288.
257. Perry HM, O'Neal RM, Thomas WA Pulmonary disease following chronic chemical ganglionic blockade. Am J Med 1957, 22:37-50.
258. Beaudry C, Laplante L Severe allergic pneumonitis from hydrochlorothiazide. Ann Intern Med 1973, 78(2):251-253.
259. Kaufman A, Montilla E, Helfgott M, et al. Pneumonitis and hydrochlorothiazide. Ann Intern Med 1973, 79(2):282-283.
260. Dorn MR, Walker BK Noncardiogenic pulmonary edema associated with hydrochlorothiazide therapy. Chest 1981, 79(4):482-483.
261. Tengstrand B, Ernestam S, Engvall IL, et al. TNF blockade in rheumatoid arthritis can cause severe fibrosing alveolitis. Six case reports. Lakartidningen 2005, 102(49):3788-3790. 3793.
262. Cordonnier C, Vernant JP, Mital P, et al. Pulmonary fibrosis subsequent to high doses of CCNU for chronic myeloid leukemia. Cancer 1983, 51(10):1814-1818.
263. Myers JL Pathology of drug-induced lung disease. Katzenstein and Askin's Surgical Pathology of Non-Neoplastic Lung Disease 1997, 81-111. WB Saunders, Philadelphia. A.L. Katzenstein (Ed.).
264. Imokawa S, Colby TV, Leslie KO, Helmers RA Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 2000, 15(2):373-381.
265. Bentur L, Bar-Kana Y, Livni E, et al. Severe minocycline-induced eosinophilic pneumonia: extrapulmonary manifestations and the use of in vitro immunoassays. Ann Pharmacother 1997, 31(6):733-735.
266. Piperno D, Donné C, Loire R, Cordier JF Bronchiolitis obliterans organizing pneumonia associated with minocycline therapy: a possible cause. Eur Respir J 1995, 8(6):1018-1020.
267. Waldhorn RE, Tsou E, Smith FP, Kerwin DM Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma. Med Pediatr Oncol 1984, 12(6):394-396.
268. Fielding JW, Crocker J, Stockley RA, Brookes VS Interstitial fibrosis in a patient treated with 5-fluorouracil and mitomycin C. BMJ 1979, 2(6189):551-552.
269. Israel KS, Brashear RE, Sharma HM, Yum MN, Glover JL Pulmonary fibrosis and nitrofurantoin. Am Rev Respir Dis 1973, 108(2):353-356.
270. Geller M, Dickie HA, Kass DA, Hafez GR, Gillespie JJ The histopathology of acute nitrofurantoin-associated pneumonitis. Ann Allergy 1976, 37(4):275-279.
271. Magee F, Wright JL, Chan N, et al. Two unusual pathological reactions to nitrofurantoin: case reports. Histopathology 1986, 10(7):701-706.
272. Ayoub JP, North L, Greer J, Cabanillas F, Younes A Pulmonary changes in patients with lymphoma who receive paclitaxel. J Clin Oncol 1997, 15(6):2476.
273. Epler GR, Snider GL, Gaensler EA, et al. Bronchiolitis and bronchitis in connective tissue disease. A possible relationship to the use of penicillamine. JAMA 1979, 242(6):528-532.
274. Sternlieb I, Bennett B, Scheinberg IH d-Penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med 1975, 82(5):673-676.
275. Davies D, Jones JK Pulmonary eosinophilia caused by penicillamine. Thorax 1980, 35(12):957-958.
276. Chamberlain DW, Hyland RH, Ross DJ Diphenylhydantoin-induced lymphocytic interstitial pneumonia. Chest 1986, 90(3):458-460.
277. Michael JR, Rudin ML Acute pulmonary disease caused by phenytoin. Ann Intern Med 1981, 95(4):452-454.
278. Dohner VA, Ward HP, Standord RE Alveolitis during procarbazine, vincristine and cyclophosphamide therapy. Chest 1972, 62(5):636-639.
279. Farney RJ, Morris AH, Armstrong JD, Hammer S Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. Am Rev Respir Dis 1977, 115(1):135-145.
280. Horton LW, Chappell AG, Powell DE Diffuse interstitial pulmonary fibrosis complicating Hodgkin's disease. Br J Dis Chest 1977, 71(1):44-48.
281. Gonzalez-Rothi RJ, Zander DS, Ros PR Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest 1995, 107(6):1763-1765.
282. Burton C, Kaczmarski R, Jan-Mohamed R Interstitial pneumonitis related to rituximab therapy. N Engl J Med 2003, 348(26):2690-2691. [discussion 2690-2691].
283. Parry SD, Barbatzas C, Peel ET, Barton JR Sulphasalazine and lung toxicity. Eur Respir J 2002, 19(4):756-764.
284. Travis WD, Kalafer ME, Robin HS, Luibel FJ Hypersensitivity pneumonitis and pulmonary vasculitis with eosinophilia in a patient taking an l-tryptophan preparation. Ann Intern Med 1990, 112(4):301-303.
285. Catton CK, Elmer JC, Whitehouse AC, Clode JB, Hustrulid RI Pulmonary involvement in the eosinophilia-myalgia syndrome. Chest 1991, 99(2):327-329.
286. Calvo DB, Legha SS, McKelvey EM, Bodey GP, Dail DH Zinostatin-related pulmonary toxicity. Cancer Treat Rep 1981, 65(1-2):165-167.
287. Zitnik RJ, Matthay RA Drug-induced lung disease. Interstitial Lung Disease 1998, 423-449. BC Decker, London. M.I. Schwartz, T.E. King (Eds.).
288. Kudoh S, Kato H, Nishiwaki Y, et al. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study. Am J Respir Crit Care Med 2008, 177(12):1348-1357.
289. Sostman HD, Matthay RA, Putman CE, Smith GJ Methotrexate-induced pneumonitis. Medicine (Baltimore) 1976, 55(5):371-388.
290. Goodman TA, Polisson RP Methotrexate: adverse reactions and major toxicities. Rheum Dis Clin North Am 1994, 20(2):513-528.
291. Bedrossian CW, Miller WC, Luna MA Methotrexate-induced diffuse interstitial pulmonary fibrosis. South Med J 1979, 72(3):313-318.
292. Zisman DA, McCune WJ, Tino G, Lynch JP Drug-induced pneumonitis: the role of methotrexate. Sarcoidosis Vasc Diffuse Lung Dis 2001, 18(3):243-252.
293. Dusman RE, Stanton MS, Miles WM, et al. Clinical features of amiodarone-induced pulmonary toxicity. Circulation 1990, 82(1):51-59.
294. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med 2004, 170(12):1324-1330.
295. Fraire AE, Guntupalli KK, Greenberg SD, Cartwright J, Chasen MH Amiodarone pulmonary toxicity: a multidisciplinary review of current status. South Med J 1993, 86(1):67-77.
296. Nicholson AA, Hayward C The value of computed tomography in the diagnosis of amiodarone-induced pulmonary toxicity. Clin Radiol 1989, 40(6):564-567.
297. Kuhlman JE, Teigen C, Ren H, et al. Amiodarone pulmonary toxicity: CT findings in symptomatic patients. Radiology 1990, 177(1):121-125.
298. Myers JL, Kennedy JI, Plumb VJ Amiodarone lung: pathologic findings in clinically toxic patients. Hum Pathol 1987, 18(4):349-354.
299. Martin WJ, Rosenow EC Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I). Chest 1988, 93(5):1067-1075.
300. Martin WJ, Rosenow EC Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part 2). Chest 1988, 93(6):1242-1248.
301. Gonzalez-Rothi RJ, Hannan SE, Hood CI, Franzini DA Amiodarone pulmonary toxicity presenting as bilateral exudative pleural effusions. Chest 1987, 92(1):179-182.
302. Wood DL, Osborn MJ, Rooke J, Holmes DR Amiodarone pulmonary toxicity: report of two cases associated with rapidly progressive fatal adult respiratory distress syndrome after pulmonary angiography. Mayo Clin Proc 1985, 60(9):601-603.
303. Van Mieghem W, Coolen L, Malysse I, et al. Amiodarone and the development of ARDS after lung surgery. Chest 1994, 105(6):1642-1645.
304. Durant JR, Norgard MJ, Murad TM, Bartolucci AA, Langford KH Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU). Ann Intern Med 1979, 90(2):191-194.
305. Ruoff M, Estey E, et al. Irreversible pulmonary toxicity after single course of BCNU. Am J Med Sci 1980, 279(1):53-56. Lieberman A.
306. Litam JP, Dail DH, Spitzer G, et al. Early pulmonary toxicity after administration of high-dose BCNU. Cancer Treat Rep 1981, 65(1-2):39-44.
307. Cao TM, Negrin RS, Stockerl-Goldstein KE, et al. Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant 2000, 6(4):387-394.
308. Holoye PY, Jenkins DE, Greenberg SD Pulmonary toxicity in long-term administration of BCNU. Cancer Treat Rep 1976, 60(11):1691-1694.
309. O'Driscoll BR, Hasleton PS, Taylor PM, et al. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990, 323(6):378-382.
310. Parish JM, Muhm JR, Leslie KO Upper lobe pulmonary fibrosis associated with high-dose chemotherapy containing BCNU for bone marrow transplantation. Mayo Clin Proc 2003, 78(5):630-634.
311. Cooper JA, White DA, Matthay RA Drug-induced pulmonary disease. Part 1: cytotoxic drugs. Am Rev Respir Dis 1986, 133(2):321-340.
312. Kreisman H, Wolkove N Pulmonary toxicity of antineoplastic therapy. Semin Oncol 1992, 19(5):508-520.
313. Holoye PY, Luna MA, MacKay B, Bedrossian CW Bleomycin hypersensitivity pneumonitis. Ann Intern Med 1978, 8:47-49.
314. Hay JG, Haslam PL, Dewar A, et al. Development of acute lung injury after the combination of intravenous bleomycin and exposure to hyperoxia in rats. Thorax 1987, 42(5):374-382.
315. Borzone G, Moreno R, Urrea R, et al. Bleomycin-induced chronic lung damage does not resemble human idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001, 163(7):1648-1653.
316. Lien HH, Brodahl U, Telhaug R, Holthe H, Fosså SD Pulmonary changes at computed tomography in patients with testicular carcinoma treated with cis-platinum, vinblastine and bleomycin. Acta Radiol Diagn (Stockh) 1985, 26(5):507-510.
317. Adler KB, Callahan LM, Evans JN Cellular alterations in the alveolar wall in bleomycin-induced pulmonary fibrosis in rats. An ultrastructural morphometric study. Am Rev Respir Dis 1986, 133(6):1043-1048.
318. Lazo JS Bleomycin. Cancer Chemother Biol Response Modif 1999, 18:39-45.
319. Bowler RP, Nicks M, Warnick K, Crapo JD Role of extracellular superoxide dismutase in bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol 2002, 282(4):L719-L726.
320. Taatjes DJ, Leslie KO, von Turkovich M, et al. Alveolocapillary remodeling in bleomycin-induced rat lung injury: interpretation from lectin-binding studies. Prog Histochem Cytochem 1991, 23(1-4):194-199.
321. Cohen MH, Williams GA, Sridhara R, Chen G, Pazdur R FDA drug approval summary: gefitinib (ZD1839) (Iressa) tablets. Oncologist 2003, 8(4):303-306.
322. Ando M, Okamoto I, Yamamoto N, et al. Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 2006, 24(16):2549-2556.
323. Ostör AJ, Chilvers ER, Somerville MF, et al. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis. J Rheumatol 2006, 33(3):622-628.
324. White DA, Camus P, Endo M, et al. Noninfectious pneumonitis after everolimus therapy for advanced renal cell carcinoma. Am J Respir Crit Care Med 2010, 182(3):396-403.
325. Maroto JP, Hudes G, Dutcher JP, et al. Drug-related pneumonitis in patients with advanced renal cell carcinoma treated with temsirolimus. J Clin Oncol 2011, 29(13):1750-1756.
326. Stern W, Subbarao K Pulmonary complications of drug addiction. Semin Roentgenol 1983, 28:183-197.
327. Abraham J, Brambilla C Particle size for differentiation between inhalation and injection pulmonary talcosis. Environ Res 1980, 21(1):94-96.
328. Abraham JL Identification and quantitative analysis of tissue particulate burden. Ann N Y Acad Sci 1984, 428:60-67.
329. Abraham JL, Burnett BR, Hunt A Development and use of a pneumoconiosis database of human pulmonary inorganic particulate burden in over 400 lungs. Scanning Microsc 1991, 5(1):95-104. [discussion 105-108].
330. Tomashefski J, Hirsch C The pulmonary vascular lesions of intravenous drug abuse. Hum Pathol 1980, 11:133-145.
331. Crouch E, Churg A Progressive massive fibrosis of the lung secondary to intravenous injection of talc. A pathologic and mineralogical analysis. Am J Clin Pathol 1983, 80:520-526.
332. Stern EJ, Frank MS, Schmutz JF, et al. Panlobular pulmonary emphysema caused by i.v. injection of methylphenidate (Ritalin): findings on chest radiographs and CT scans. AJR Am J Roentgenol 1994, 162:555-560.
333. Schiavina M, Di Scioscio V, Contini P, et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 2007, 176(1):96-98.
334. Cheung OY, Muhm JR, Helmers RA, et al. Surgical pathology of granulomatous interstitial pneumonia. Ann Diagn Pathol 2003, 7(2):127-138.
335. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16(2):149-173.
336. Stirling RG, Cullinan P, Du Bois RMP Sarcoidosis. Interstitial Lung Disease 1998, 279-322. BC Decker, London. M.I. Schwartz, T.E. King (Eds.).
337. Milman N, Selroos O Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture. Sarcoidosis 1990, 7(1):50-57.
338. Milman N, Selroos O Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis 1990, 7(2):113-118.
339. Sartwell PE, Edwards LB Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol 1974, 99(4):250-257.
340. Lynch DA, Webb WR, Gamsu G, et al. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 1989, 13:405-410.
341. Kuhlman JE, Fishman EK, Hamper UM, Knowles M, Siegelman SS The computed tomographic spectrum of thoracic sarcoidosis. Radiographics 1989, 9(3):449-466.
342. Müller NL, Kullnig P, Miller RR The CT findings of pulmonary sarcoidosis: analysis of 25 patients. AJR Am J Roentgenol 1989, 152(6):1179-1182.
343. Padley SP, Padhani AR, Nicholson A, Hansell DM Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT. Clin Radiol 1996, 51(11):807-810.
344. Abehsera M, Valeyre D, Grenier P, et al. Sarcoidosis with pulmonary fibrosis: CT patterns and correlation with pulmonary function. AJR Am J Roentgenol 2000, 174(6):1751-1757.
345. Battesti JP, Saumon G, Valeyre D, et al. Pulmonary sarcoidosis with an alveolar radiographic pattern. Thorax 1982, 37:448-452.
346. Gilman MJ, Wang KP Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980, 122(5):721-724.
347. Hsu RM, Connors AF, Tomashefski JF Histologic, microbiologic, and clinical correlates of the diagnosis of sarcoidosis by transbronchial biopsy. Arch Pathol Lab Med 1996, 120(4):364-368.
348. Freiman D, Hardy H Beryllium disease: the relation of pulmonary pathology to clinical course and prognosis based on a study of 130 cases from the US Beryllium Case Registry. Hum Pathol 1970, 1:25-44.
349. Matilla A, Galera H, Pascual E, Carapeto R Chronic berylliosis. Br J Dis Chest 1973, 67:308-314.
350. Aronchik JM, Rossman MD, Miller WT Chronic beryllium disease: diagnosis, radiographic findings, and correlation with pulmonary function tests. Radiology 1987, 163:677-678.
351. Kriebel D, Brain JD, Sprince NL, Kazemi H The pulmonary toxicity of beryllium. Am Rev Respir Dis 1988, 137(2):464-473.
352. Kriebel D, Sprince NL, Eisen EA, Greaves IA Pulmonary function in beryllium workers: assessment of exposure. Br J Ind Med 1988, 45(2):83-92.
353. Kriebel D, Sprince NL, Eisen EA, et al. Beryllium exposure and pulmonary function: a cross sectional study of beryllium workers. Br J Ind Med 1988, 45(3):167-173.
354. Maier LA, Martyny JW, Liang J, Rossman MD Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med 2008, 177(9):1012-1017.
355. Kawanami O, Basset F, Barrios R, et al. Hypersensitivity pneumonitis in man: light- and electron-microscopic studies of 18 lung biopsies. Am J Pathol 1983, 110:275-289.
356. Salvaggio J, Karr R Hypersensitivity pneumonitis: state of the art. Chest 1979, 75(suppl 2):270-274.
357. Wild LG, Lopez M Hypersensitivity pneumonitis: a comprehensive review. J Investig Allergol Clin Immunol 2001, 11(1):3-15.
358. Bourke SJ, Dalphin JC, Boyd G, et al. Hypersensitivity pneumonitis: current concepts. Eur Respir J Suppl 2001, 32:81s-92s.
359. Selman M Hypersensitivity pneumonitis. Interstitial Lung Disease 1998, 393-422. BC Decker, London. M.I. Schwartz, T.E. King (Eds.).
360. McSharry C, Banham SW, Boyd G Effect of cigarette smoking on the antibody response to inhaled antigens and the prevalence of extrinsic allergic alveolitis among pigeon breeders. Clin Allergy 1985, 15:487.
361. Patel AM, Ryu JH, Reed CE Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol 2001, 108(5):661-670.
362. Glazer C, Rose C, Lynch D Clinical and radiologic manifestations of hypersensitivity pneumonitis. J Thorac Imaging 2002, 17(4):261-272.
363. Cook PG, Wells IP, McGavin CR The distribution of pulmonary shadowing in farmer's lung. Clin Radiol 1988, 39(1):21-27.
364. Khoor A, Leslie KO, Tazelaar HD, Helmers RA, Colby TV Diffuse pulmonary disease caused by nontuberculous mycobacteria in immunocompetent people (hot tub lung). Am J Clin Pathol 2001, 115(5):755-762.
365. Pham R, Vydareny K, Gal A High-resolution computed tomography appearance of pulmonary Mycobacterium avium complex infection after exposure to hot tub: case of hot-tub lung. J Thorac Imaging 2003, 18(1):48-52.
366. Coleman A, Colby TV Histologic diagnosis of extrinsic allergic alveolitis. Am J Surg Pathol 1988, 12(7):514-518.
367. Colby TV, Coleman A Histologic differential diagnosis of extrinsic allergic alveolitis. Prog Surg Pathol 1989, 10:11-26.
368. Seal RM, Hapke EJ, Thomas GO, Meek JC, Hayes M The pathology of the acute and chronic stages of farmer's lung. Thorax 1968, 23(5):469-489.
369. Takemura T, Akashi T, Ohtani Y, Inase N, Yoshizawa Y Pathology of hypersensitivity pneumonitis. Curr Opin Pulm Med 2008, 14(5):440-454.
370. Barbee RA, Callies Q, Dickie HA, Rankin J The long-term prognosis in farmer's lung. Am Rev Respir Dis 1968, 97(2):223-231.
371. Kokkarinen J, Tukiainen H, Seppä A, Terho EO Hypersensitivity pneumonitis due to native birds in a bird ringer. Chest 1994, 106(4):1269-1271.
372. Kokkarinen J, Tukiainen H, Terho EO Mortality due to farmer's lung in Finland. Chest 1994, 106(2):509-512.
373. Kokkarinen JI, Tukiainen HO, Terho EO Effect of corticosteroid treatment on the recovery of pulmonary function in farmer's lung. Am Rev Respir Dis 1992, 145(1):3-5.
374. Sansores R, Salas J, Chapela R, Barquin N, Selman M Clubbing in hypersensitivity pneumonitis. Its prevalence and possible prognostic role. Arch Intern Med 1990, 150(9):1849-1851.
375. Pérez-Padilla R, Gaxiola M, Salas J, et al. Bronchiolitis in chronic pigeon breeder's disease. Morphologic evidence of a spectrum of small airway lesions in hypersensitivity pneumonitis induced by avian antigens. Chest 1996, 110(2):371-377.
376. Brabencova E, Tazi A, Lorenzato M, et al. Langerhans cells in Langerhans cell granulomatosis are not actively proliferating cells. Am J Pathol 1998, 152(5):1143-1149.
377. Vassallo R, Ryu JH, Colby TV, Hartman T, Limper AH Pulmonary Langerhans'-cell histiocytosis. N Engl J Med 2000, 342(26):1969-1978.
378. Willman CL, Busque L, Griffith BB, et al. Langerhans'-cell histiocytosis (histiocytosis X)-a clonal proliferative disease. N Engl J Med 1994, 331(3):154-160.
379. Travis WD, Borok Z, Roum JH, et al. Pulmonary Langerhans cell granulomatosis (histiocytosis X). A clinicopathologic study of 48 cases. Am J Surg Pathol 1993, 17(10):971-986.
380. Parambil JG, Myers JL, Aubry MC, Ryu JH Causes and prognosis of diffuse alveolar damage diagnosed on surgical lung biopsy. Chest 2007, 132(1):50-57.
381. Colby TV, Lombard C Histiocytosis X in the lung. Hum Pathol 1983, 14(10):847-856.
382. Niku S, Stark P, Levin DL, Friedman PJ Lymphangioleiomyomatosis: clinical, pathologic, and radiologic manifestations. J Thorac Imaging 2005, 20(2):98-102.
383. Lacronique J, Roth C, Battesti JP, Basset F, Chretien J Chest radiological features of pulmonary histiocytosis X: a report based on 50 adult cases. Thorax 1982, 37(2):104-109.
384. Moore AD, Godwin JD, Müller NL, et al. Pulmonary histiocytosis X: comparison of radiographic and CT findings. Radiology 1989, 172(1):249-254.
385. Kulwiec EL, Lynch DA, Aguayo SM, Schwarz MI, King TE Imaging of pulmonary histiocytosis X. Radiographics 1992, 12(3):515-526.
386. Brauner MW, Grenier P, Tijani K, Battesti JP, Valeyre D Pulmonary Langerhans cell histiocytosis: evolution of lesions on CT scans. Radiology 1997, 204(2):497-502.
387. Kambouchner M, Basset F, Marchal J, et al. Three-dimensional characterization of pathologic lesions in pulmonary Langerhans cell histiocytosis. Am J Respir Crit Care Med 2002, 166(11):1419-1421.
388. McDonnell TJ, Crouch EC, Gonzalez JG Reactive eosinophilic pleuritis. A sequela of pneumothorax in pulmonary eosinophilic granuloma. Am J Clin Pathol 1989, 91(1):107-111.
389. Askin FB, McCann BG, Kuhn C Reactive eosinophilic pleuritis: a lesion to be distinguished from pulmonary eosinophilic granuloma. Arch Pathol Lab Med 1977, 101:187-192.
390. Schonfeld N, Dirks K, Costabel U, Loddenkemper R Wissenschaftliche Arbeitsgemeinschaft fur die Therapie von Lungenkrankheiten. A prospective clinical multicentre study on adult pulmonary Langerhans' cell histiocytosis. Sarcoidosis Vasc Diffuse Lung Dis 2012, 29(2):132-138.
391. Le Pavec J, Lorillon G, Jais X, et al. Pulmonary Langerhans cell histiocytosis-associated pulmonary hypertension: clinical characteristics and impact of pulmonary arterial hypertension therapies. Chest 2012, 142(5):1150-1157.
392. Delobbe A, Durieu J, Duhamel A, Wallaert B Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Eur Respir J 1996, 9(10):2002-2006.
393. Veyssier-Belot C, Cacoub P, Caparros-Lefebvre D, et al. Erdheim-Chester disease. Clinical and radiologic characteristics of 59 cases. Medicine (Baltimore) 1996, 75(3):157-169.
394. Cottin V, Nunes H, Brillet PY, et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005, 26(4):586-593.
395. Bisceglia M, Cammisa M, Suster S, Colby TV Erdheim-Chester disease: clinical and pathologic spectrum of four cases from the Arkadi M. Rywlin slide seminars. Adv Anat Pathol 2003, 10(3):160-171.
396. Bancroft LW, Berquist TH Erdheim-Chester disease: radiographic findings in five patients. Skeletal Radiol 1998, 27(3):127-132.
397. Breuil V, Brocq O, Pellegrino C, Grimaud A, Euller-Ziegler L Erdheim-Chester disease: typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum Dis 2002, 61(3):199-200.
398. Gottlieb R, Chen A MR findings of Erdheim-Chester disease. J Comput Assist Tomogr 2002, 26(2):257-261.
399. Olmos JM, Canga A, Velero C, González-Macías J Imaging of Erdheim-Chester disease. J Bone Miner Res 2002, 17(3):381-383.
400. Kambouchner M, Colby TV, Domenge C, et al. Erdheim-Chester disease with prominent pulmonary involvement associated with eosinophilic granuloma of mandibular bone. Histopathology 1997, 30(4):353-358.
401. Egan AJ, Boardman LA, Tazelaar HD, et al. Erdheim-Chester disease: clinical, radiologic, and histopathologic findings in five patients with interstitial lung disease. Am J Surg Pathol 1999, 23(1):17-26.
402. Rush WL, Andriko JA, Galateau-Salle F, et al. Pulmonary pathology of Erdheim-Chester disease. Mod Pathol 2000, 13(7):747-754.
403. Wittenberg KH, Swensen SJ, Myers JL Pulmonary involvement with Erdheim-Chester disease: radiographic and CT findings. AJR Am J Roentgenol 2000, 174(5):1327-1331.
404. Shamburek RD, Brewer HB, Gochuico BR Erdheim-Chester disease: a rare multisystem histiocytic disorder associated with interstitial lung disease. Am J Med Sci 2001, 321(1):66-75.
405. Taylor JR, Ryu J, Colby TV, Raffin TA Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990, 323(18):1254-1260.
406. Kitaichi M, Nishimura K, Itoh H, Izumi T Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995, 151(2 pt1):527-533.
407. Kalassian KG, Doyle R, Kao P, Ruoss S, Raffin TA Lymphangioleiomyomatosis: new insights. Am J Respir Crit Care Med 1997, 155(4):1183-1186.
408. Athavale A, Chhajed P, Singhal P, et al. Pulmonary lymphangioleiomyomatosis. J Assoc Physicians India 1999, 47(6):649-650.
409. Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1999, 78(5):321-337.
410. Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999, 115(4):1041-1052.
411. Cancer IAfRo, Cancer Cidrsl WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart 2015, IARC.
412. Costello LC, Hartman TE, Ryu JH High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000, 75(6):591-594.
413. Sato T, Seyama K, Fujii H, et al. Mutation analysis of the TSC1 and TSC2 genes in Japanese patients with pulmonary lymphangioleiomyomatosis. J Hum Genet 2002, 47(1):20-28.
414. Yu J, Astrinidis A, Henske EP Chromosome 16 loss of heterozygosity in tuberous sclerosis and sporadic lymphangiomyomatosis. Am J Respir Crit Care Med 2001, 164(8 pt1):1537-1540.
415. Carsillo T, Astrinidis A, Henske EP Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA 2000, 97(11):6085-6090.
416. Aubry MC, Myers JL, Ryu JH, et al. Pulmonary lymphangioleiomyomatosis in a man. Am J Respir Crit Care Med 2000, 162(2 Pt 1):749-752.
417. Lack EE, Dolan MF, Finisio J, et al. Pulmonary and extrapulmonary lymphangioleiomyomatosis. Report of a case with bilateral renal angiomyolipomas, multifocal lymphangioleiomyomatosis, and a glial polyp of the endocervix. Am J Surg Pathol 1986, 10(9):650-657.
418. Uzzo RG, Libby DM, Vaughan ED, Levey SH Coexisting lymphangioleiomyomatosis and bilateral angiomyolipomas in a patient with tuberous sclerosis. J Urol 1994, 151(6):1612-1615.
419. Bernstein SM, Newell JD, Adamczyk D, et al. How common are renal angiomyolipomas in patients with pulmonary lymphangiomyomatosis. Am J Respir Crit Care Med 1995, 152(6 pt1):2138-2143.
420. Maziak DE, Kesten S, Rappaport DC, Maurer J Extrathoracic angiomyolipomas in lymphangioleiomyomatosis. Eur Respir J 1996, 9(3):402-405.
421. Neumann HP, Schwarzkopf G, Henske EP Renal angiomyolipomas, cysts, and cancer in tuberous sclerosis complex. Semin Pediatr Neurol 1998, 5(4):269-275.
422. Tüzel E, Kirkali Z, Mungan U, Cüler C, Sade M Giant angiomyolipoma associated with marked pulmonary lesions suggesting lymphangioleiomyomatosis in a patient with tuberous sclerosis. Int Urol Nephrol 2000, 32(2):219-222.
423. Müller NL, Chiles C, Kullnig P Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990, 175(2):335-339.
424. Rappaport DC, Weisbrod GL, Herman SJ, Chamberlain DW Pulmonary lymphangioleiomyomatosis: high-resolution CT findings in four cases. AJR Am J Roentgenol 1989, 152(5):961-964.
425. Templeton PA, McLoud TC, Müller NL, et al. Pulmonary lymphangioleiomyomatosis: CT and pathologic findings. J Comput Assist Tomogr 1989, 13(1):54-57.
426. Sherrier RH, Chiles C, Roggli V Pulmonary lymphangioleiomyomatosis: CT findings. AJR Am J Roentgenol 1989, 153(5):937-940.
427. Kirchner J, Stein A, Viel K, et al. Pulmonary lymphangioleiomyomatosis: high-resolution CT findings. Eur Radiol 1999, 9(1):49-54.
428. Kumasaka T, Seyama K, Mitani K, et al. Lymphangiogenesis-mediated shedding of LAM cell clusters as a mechanism for dissemination in lymphangioleiomyomatosis. Am J Surg Pathol 2005, 29(10):1356-1366.
429. Flavin RJ, Cook J, Fiorentino M, et al. -Catenin is a useful adjunct immunohistochemical marker for the diagnosis of pulmonary lymphangioleiomyomatosis. Am J Clin Pathol 2011, 135(5):776-782.
430. Toro JR, Wei MH, Glenn GM, et al. BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports. J Med Genet 2008, 45(6):321-331.
431. Shen A, Iseman MD, Waldron JA, King TE Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 1987, 91(5):782-785.
432. Eliasson AH, Phillips YY, Tenholder MF Treatment of lymphangioleiomyomatosis. A meta-analysis. Chest 1989, 96(6):1352-1355.
433. Ohori NP, Yousem SA, Sonmez-Alpan E, Colby TV Estrogen and progesterone receptors in lymphangioleiomyomatosis, epithelioid hemangioendothelioma, and sclerosing hemangioma of the lung. Am J Clin Pathol 1991, 96(4):529-535.
434. Rajjoub S, Blatt MW, Ritterspach J Response to treatment with progesterone in a patient with pulmonary lymphangioleiomyomatosis. W V Med J 1995, 91(7):322-323.
435. Colley MH, Geppert E, Franklin WA Immunohistochemical detection of steroid receptors in a case of pulmonary lymphangioleiomyomatosis. Am J Surg Pathol 1989, 13(9):803-807.
436. McCormack FX Lymphangioleiomyomatosis: a clinical update. Chest 2008, 133(2):507-516.
437. Boehler A, Speich R, Russi EW, Weder W Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996, 335(17):1275-1280.
438. Bittmann I, Dose TB, Müller C, et al. Lymphangioleiomyomatosis: recurrence after single lung transplantation. Hum Pathol 1997, 28(12):1420-1423.
439. Gunji Y, Akiyoshi T, Sato T, et al. Mutations of the Birt Hogg Dube gene in patients with multiple lung cysts and recurrent pneumothorax. J Med Genet 2007, 44(9):588-593.
440. Davies BH, Tuddenham EG Familial pulmonary fibrosis associated with oculocutaneous albinism and platelet function defect. A new syndrome. Q J Med 1976, 45(178):219-232.
441. DePinho RA, Kaplan KL The Hermansky-Pudlak syndrome. Report of three cases and review of pathophysiology and management considerations. Medicine (Baltimore) 1985, 64(3):192-202.
442. Dimson O, Drolet BA, Esterly NB Hermansky-Pudlak syndrome. Pediatr Dermatol 1999, 16(6):475-477.
443. Huizing M, Gahl WA Disorders of vesicles of lysosomal lineage: the Hermansky-Pudlak syndromes. Curr Mol Med 2002, 2(5):451-467.
444. Pierson DM, Ionescu D, Qing G, et al. Pulmonary fibrosis in Hermansky-Pudlak syndrome. A case report and review. Respiration 2006, 73(3):382-395.
445. Anikster Y, Huizing M, White J, et al. Mutation of a new gene causes a unique form of Hermansky-Pudlak syndrome in a genetic isolate of central Puerto Rico. Nat Genet 2001, 28(4):376-380.
446. Hermos CR, Huizing M, Kaiser-Kupfer MI, Gahl WA Hermansky-Pudlak syndrome type 1: gene organization, novel mutations, and clinical-molecular review of non-Puerto Rican cases. Hum Mutat 2002, 20(6):482.
447. Okano A, Sato A, Chida K, et al. Pulmonary interstitial pneumonia in association with Hermansky-Pudlak syndrome. Nihon Kyobu Shikkan Gakkai Zasshi 1991, 29(12):1596-1602.
448. Avila NA, Brantly M, Premkumar A, et al. Hermansky-Pudlak syndrome: radiography and CT of the chest compared with pulmonary function tests and genetic studies. AJR Am J Roentgenol 2002, 179(4):887-892.
449. Nakatani Y, Nakamura N, Sano J, et al. Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes. Virchows Arch 2000, 437(3):304-313.
450. Gahl WA, Brantly M, Troendle J, et al. Effect of pirfenidone on the pulmonary fibrosis of Hermansky-Pudlak syndrome. Mol Genet Metab 2002, 76(3):234-242.
451. Sosman MC, Dodd GD, Jones WD, Pillmore GU The familial occurrence of pulmonary alveolar microlithiasis. Am J Roentgenol Radium Ther Nucl Med 1957, 77:947-952.
452. Fuleihan FJ, Abboud RT, Balikian JP, Nucho CK Pulmonary alveolar microlithiasis: lung function in five cases. Thorax 1969, 24:84-90.
453. Prakash UB, Barham SS, Rosenow EC, Brown ML, Payne WS Pulmonary alveolar microlithiasis. A review including ultrastructural and pulmonary function studies. Mayo Clin Proc 1983, 58(5):290-300.
454. Edelweiss M, Medeiros LJ, Suster S, Moran CA Lymph node involvement by Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical study of 20 cases. Hum Pathol 2007, 38(10):1463-1469.
455. Castellana G, Gentile M, Castellana R, Fiorente P, Lamorgese V Pulmonary alveolar microlithiasis: clinical features, evolution of the phenotype, and review of the literature. Am J Med Genet 2002, 111(2):220-224.
456. Senyiit A, Yarami A, Gürkan F, et al. Pulmonary alveolar microlithiasis: a rare familial inheritance with report of six cases in a family. Contribution of six new cases to the number of case reports in Turkey. Respiration 2001, 68(2):204-209.
457. Huqun IS, Miyazawa H, Ishii K, et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 2007, 175(3):263-268.
458. Pant K, Shah A, Mathur RK, Chhabra SK, Jain SK Pulmonary alveolar microlithiasis with pleural calcification and nephrolithiasis. Chest 1990, 98:245-246.
459. Chang Y, Yang PC, Luh KT, Tsang YM, Su CT High-resolution computed tomography of pulmonary alveolar microlithiasis. J Formos Med Assoc 1999, 98(6):440-443.
460. Trapnell BC, Whitsett JA, Nakata K Pulmonary alveolar proteinosis. N Engl J Med 2003, 349(26):2527-2539.
461. Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 2008, 177(7):752-762.
462. Kitamura T, Tanaka N, Watanabe J, et al. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor. J Exp Med 1999, 190(6):875-880.
463. Singh G, Katyal SL, Bedrossian CW, Rogers RM Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it. Chest 1983, 83:82-86.
464. Miller RR, Churg AM, Hutcheon M, Lom S Pulmonary alveolar proteinosis and aluminum dust exposure. Am Rev Respir Dis 1984, 130:312-315.
465. Bedrossian CW, Luna MA, Conklin RH, Miller WC Alveolar proteinosis as a consequence of immunosuppression. A hypothesis based on clinical and pathologic observations. Hum Pathol 1980, 11(suppl 5):527-535.
466. Wang Y, Xia J, Wang QW Clinical report on 62 cases of acute dimethyl sulfate intoxication. Am J Ind Med 1988, 13(4):455-462.
467. Seymour J, Presneill J Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002, 166(2):215-235.
468. Shah P, Hansell D, Lawson PR, Reid K, Morgan C Pulmonary alveolar proteinosis: clinical aspects and current concepts in pathogenesis. Thorax 2000, 55:67-77.
469. Davidson J, Mac Leod W Pulmonary alveolar proteinosis. Br J Dis Chest 1969, 63:13-16.
470. Lynch DA, Godwin JD, Safrin S, et al. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med 2005, 172(4):488-493.
471. Claypool W, Roger R, Matuschak G Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984, 85:550-558.
472. Wylam ME, Ten R, Prakash UB, et al. Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis. Eur Respir J 2006, 27(3):585-593.
473. Tazawa R, Hamano E, Arai T, et al. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis. Am J Respir Crit Care Med 2005, 171(10):1142-1149.
474. Heitzman E The Lung: Radiologic-Pathologic Correlations 1984, Mosby, St. Louis. 2nd ed.
475. Munk PL, Müller NL, Miller RR, Ostrow DN Pulmonary lymphangitic carcinomatosis: CT and pathologic findings. Radiology 1988, 166:705-709.
476. Janower M, Blennerhassett J Lymphangitic spread of metastatic cancer to the lung: a radiologic-pathologic classification. Radiology 1971, 101:267-273.
477. Stein MG, Mayo J, Müller N, et al. Pulmonary lymphangitic spread of carcinoma: appearance on CT scans. Radiology 1987, 162:371-375.
478. Goldsmith HS, Bailey HD, Callahan EL, Beattie EJ Pulmonary lymphangitic metastases from breast carcinoma. Arch Surg 1967, 94:483-488.
479. Wall CP, Gaensler EA, Carrington CB, Hayes JA Comparison of transbronchial and open biopsies in chronic infiltrative lung disease. Am Rev Respir Dis 1981, 123:280-285.
480. Suster S, Moran CA Diffuse pulmonary meningotheliomatosis. Am J Surg Pathol 2007, 31(4):624-631.
481. Ionescu DN, Sasatomi E, Aldeeb D, et al. Pulmonary meningothelial-like nodules: a genotypic comparison with meningiomas. Am J Surg Pathol 2004, 28(2):207-214.
482. Chapel H, Lucas M, Patel S, et al. Confirmation and improvement of criteria for clinical phenotyping in common variable immunodeficiency disorders in replicate cohorts. J Allergy Clin Immunol 2012, 130(5):1197-1198. e1199.
483. Boursiquot JN, Gerard L, Malphettes M, et al. Granulomatous disease in CVID: retrospective analysis of clinical characteristics and treatment efficacy in a cohort of 59 patients. J Clin Immunol 2013, 33(1):84-95.
484. Maglione PJ, Overbey JR, Radigan L, Bagiella E, Cunningham-Rundles C Pulmonary radiologic findings in common variable immunodeficiency: clinical and immunological correlations. Ann Allergy Asthma Immunol 2014, 113(4):452-459.
485. Chase NM, Verbsky JW, Hintermeyer MK, et al. Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID). J Clin Immunol 2013, 33(1):30-39.
486. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344(10):732-738.
487. Shrestha B, Sekiguchi H, Colby TV, et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 2009, 33(10):1450-1462.
488. Ryu JH, Sekiguchi H, Yi ES Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur Respir J 2012, 39(1):180-186.
489. Peikert T, Shrestha B, Aubry MC, et al. Histopathologic overlap between fibrosing mediastinitis and IgG4-related disease. Int J Rheumatol 2012, 2012:207056.
490. Kuranishi LT, Leslie KO, Ferreira RG, et al. Airway-centered interstitial fibrosis: etiology, clinical findings and prognosis. Respir Res 2015, 16:55.
491. Smith ML Update on pulmonary fibrosis: not all fibrosis is created equally. Arch Pathol Lab Med 2016, 140(3):221-229.
492. Takemura T, Akashi T, Kamiya H, et al. Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia. Histopathology 2012, 61(6):1026-1035.
493. Katzenstein AL Smoking-related interstitial fibrosis (SRIF): pathologic findings and distinction from other chronic fibrosing lung diseases. J Clin Pathol 2013, 66(10):882-887.
494. Mukhopadhyay S, Gal AA Granulomatous lung disease: an approach to the differential diagnosis. Arch Pathol Lab Med 2010, 134(5):667-690.
495. Hutton Klein JR, Tazelaar HD, Leslie KO, Colby TV One hundred consecutive granulomas in a pulmonary pathology consultation practice. Am J Surg Pathol 2010, 34(10):1456-1464.
496. Homma Y, Ohtsuka Y, Tanimura K, et al. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia. Respiration 1995, 62(5):248-251.
497. Myers JL Hypersensitivity pneumonia: the role of lung biopsy in diagnosis and management. Mod Pathol 2012, 25(suppl 1):S58-S67.
498. Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012, 25(9):1181-1192.